US Patent Issued to Alpine Immune Sciences on June 30 for "CD80 variant immunomodulatory proteins and uses thereof" (Washington Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,634, issued on June 30, was assigned to Alpine Immune Sciences Inc. (Seattle).

"CD80 variant immunomodulatory proteins and uses thereof" was invented by Ryan Swanson (Seattle) and Michael Kornacker (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided."

The patent was filed on Oct. 7, 2022, under Application N...